Date published: 2026-5-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLHL31 Inhibitors

KLHL31 inhibitors represent a specialized class of chemical compounds designed to interfere with the function of the Kelch-like protein 31 (KLHL31). KLHL31 is a member of the broader Kelch-like protein family, which is characterized by the presence of Kelch repeats-protein domains that mediate protein-protein interactions. These repeats are structurally arranged in a β-propeller formation, a conformation that allows KLHL31 to interact with various substrates and other proteins, playing a crucial role in ubiquitination processes. Ubiquitination is a post-translational modification that tags proteins for degradation via the proteasome, thereby regulating the turnover and function of numerous cellular proteins. By targeting KLHL31, inhibitors of this class modulate the ubiquitination pathway, potentially altering the stability and abundance of specific proteins within the cell. This makes KLHL31 inhibitors of particular interest in the study of protein homeostasis and the broader understanding of proteostasis mechanisms. The chemical design of KLHL31 inhibitors is typically centered around the disruption of the protein-protein interaction interface, specifically targeting the Kelch repeats that are critical for substrate recognition and binding. Structural studies of KLHL31, often involving techniques such as X-ray crystallography or cryo-electron microscopy, have revealed the detailed architecture of its Kelch domains, guiding the rational design of small molecules or peptides that can bind to these regions and block substrate interactions. These inhibitors may possess varied scaffolds, incorporating elements that enhance their affinity, specificity, and stability within the cellular environment. In addition to small molecule inhibitors, there is also interest in exploring macrocyclic compounds and peptide-based inhibitors, which can offer unique advantages in terms of binding characteristics and selectivity. Overall, KLHL31 inhibitors provide a valuable tool for dissecting the functional roles of this protein within the ubiquitin-proteasome system, thereby contributing to a deeper understanding of cellular regulation and protein degradation pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

As a DNA methyltransferase inhibitor, it may alter the methylation status of the KLHL31 gene, affecting its expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

By intercalating into DNA, it can inhibit RNA polymerase and thus reduce KLHL31 mRNA synthesis.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

This compound inhibits eukaryotic translational elongation, which can lead to reduced protein levels, including KLHL31.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Flavonoid that may modulate signaling pathways and transcription factors, potentially diminishing KLHL31 expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Known to alkalize endosomal pH and can affect cellular processes, possibly leading to decreased KLHL31 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

It inhibits RNA polymerase II, which could lead to a decrease in mRNA synthesis for genes like KLHL31.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that may affect protein turnover and indirectly reduce transcription factor availability for KLHL31 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK signaling, which may regulate transcription factors that are necessary for KLHL31 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor which might downregulate the AKT/mTOR pathway, potentially impacting KLHL31 protein synthesis.